Business

AstraZeneca to Buy Alexion in $ 39 Billion Immunology Deal

[ad_1] Anglo-Swedish pharmaceutical company AstraZeneca has agreed to buy American biotech group Alexion in a $ 39 billion deal, marking the largest deal reached by a pharmaceutical company since the start of the Covid-19 pandemic. The cash and stock acquisition will deepen AstraZeneca’s core focus on immunology, bringing a portfolio …

Read More »